Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 5/20 | 0.54 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CES1 | P23141 | 5/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.44 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60395 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL5702178 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL37390 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL3859589 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL124866 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL61429 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL1592581 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL61487 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL5969692 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 | |
| SCHEMBL782450 | 1.00 | EPHX2 (0.55) | EPHX2FAAHCA2APPCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 820 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388596-A1 | PROCESS FOR THE EXTRACTION AND PURIFICATION OF TETRODOTOXIN | WEX PHARMACEUTICALS INC (CA) | 2025-12-25 | — | — | US | claimed |
| CN-116529428-B | Tin alloy plating solution | 三菱综合材料株式会社 | 2025-03-14 | — | — | CN | claimed |
| WO-2024111308-A1 | COMPOSITION CONTAINING FLUOROIODOALKANE | 東ソー株式会社 | 2024-05-30 | — | — | WO | claimed |
| EP-4363222-A1 | THERMOPLASTIC POLYMER POWDER FOR 3D PRINTING WITH IMPROVED STABILITY AND RECYCLABILITY | ARKEMA FRANCE (FR) | 2024-05-08 | — | — | EP | claimed |
| CN-117907507-A | Analysis method for efficiently detecting cetrorelix acetate related substances for injection | 江苏诺泰澳赛诺生物制药股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117757249-A | Conductive TPU material and preparation method thereof | 美瑞新材料创新中心(山东)有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117580711-A | Thermoplastic polymer powder for 3D printing with improved stability and recycling properties | 阿科玛法国公司 | 2024-02-20 | — | — | CN | claimed |
| WO-2024007068-A1 | PROCESS FOR THE EXTRACTION AND PURIFICATION OF TETRODOTOXIN | WEX PHARMACEUTICALS INC. (CA) | 2024-01-11 | — | — | WO | claimed |
| CN-117269359-A | Method for measuring cysteine content in compound amino acid injection | 四川太平洋药业有限责任公司 | 2023-12-22 | — | — | CN | claimed |
| CN-113881473-B | Environment-friendly biomass fuel | 重庆啸云环保科技有限公司 | 2023-12-22 | — | — | CN | claimed |
| WO-2006088533-A2 | METHOD AND COMPOSITION FOR ELECTRO-CHEMICAL-MECHANICAL POLISHING | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2006-08-24 | — | — | WO | claimed |
| US-20060163083-A1 | Method and composition for electro-chemical-mechanical polishing | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2006-07-27 | — | — | US | claimed |
| US-20060141445-A1 | Method for manufacturing a sensor chip and sensor chip blank | MICRONAS HOLDING GMBH (DE) | 2006-06-29 | — | — | US | claimed |
| US-20060115906-A1 | Sensor surface comprising an improved signal-noise ratio | MICRONAS HOLDING GMBH (DE) | 2006-06-01 | — | — | US | claimed |
| EP-1203063-A4 | NATURAL GAS HYDRATE AND METHOD FOR PRODUCING SAME | METASOURCE PTY LTD (AU) | 2006-03-08 | — | — | EP | claimed |
| WO-2005113797-A2 | METHODS FOR DETECTING Lp-PLA2 ACTIVITY AND INHIBITION OF Lp-PLA2 ACTIVITY | GLAXO GROUP LIMITED (GB) | 2005-12-01 | — | — | WO | claimed |
| US-20050244913-A1 | determining lipoprotein-associated phospholipase A2 (Lp-PLA2) enzyme activity and inhibition of activity; colorimetry | GLAXO GROUP LIMITED (GB) | 2005-11-03 | — | — | US | claimed |
| US-6855852-B1 | Natural gas hydrate and method for producing same | METASOURCE PTY LTD (AU) | 2005-02-15 | — | — | US | claimed |
| EP-1203063-A1 | NATURAL GAS HYDRATE AND METHOD FOR PRODUCING SAME | Metasource Pty Ltd (AU) | 2002-05-08 | — | — | EP | claimed |
| WO-2001000755-A1 | NATURAL GAS HYDRATE AND METHOD FOR PRODUCING SAME | METASOURCE PTY LTD (AU) | 2001-01-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388596-A1 | PROCESS FOR THE EXTRACTION AND PURIFICATION OF TETRODOTOXIN | TRPA1, CACNA1D, SCN2A | EPHX2 1692/4885FAAH 748/4885CA2 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.